Page 62 - Express Scripts News Today

^Ad hoc announcement pursuant to Art. 53 LR * The approximately 20 million US lives covered by CVS will now have easier and more affordable access to QUVIVIQ Allschwil, Switzerland & Radnor, PA, United States - July 10, 2023 Idorsia Ltd (SIX: IDIA) and Idorsia Pharmaceuticals US Inc. today annou...

Cigna Pharmacy Management, which supports Cigna Healthcares plans with integrated medical and pharmacy benefits, is adding four biosimilars to HUMIRA as preferred products on its formularies. ...

10.07.2023 - Ad hoc announcement pursuant to Art. 53 LR The approximately 20 million US lives covered by CVS will now have easier and more affordable access to QUVIVIQ Allschwil, Switzerland & Radnor, PA, United States – July 10, 2023Idorsia Ltd (SIX: ... Seite 1

At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients.

The panel of three judges voted 2-1 to reverse a lower court's decision that had blocked Tennessee from enforcing the law while it was being challenged. EU investigates Ozempic, weight-loss drug Saxenda after suicidal thoughts reported The European Medicines Agency (EMA) is investigating Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland's health regulator flagged three cases of patients thinking about suicide or self-harm.

At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.

At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.

At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.

At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.

At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.